Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -131,289 | -388,955 | -251,575 | -109,265 | -89,445 |
| Depreciation Amortization | 1,848 | 5,814 | 4,156 | 2,748 | 1,341 |
| Accounts receivable | -859 | 56,672 | 54,525 | 54,846 | 50,763 |
| Accounts payable and accrued liabilities | -8,106 | 4,524 | -8,524 | -11,930 | -3,080 |
| Other Working Capital | -19,172 | -24,704 | -41,544 | -53,275 | 40,492 |
| Other Operating Activity | 35,292 | 47,133 | 41,636 | -410 | -26,882 |
| Operating Cash Flow | $-122,286 | $-299,516 | $-201,326 | $-117,286 | $-26,811 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -402 | -11,335 | -8,130 | -1,799 | -942 |
| Purchase Of Investment | -89,779 | -855,393 | -730,214 | -263,037 | -193,127 |
| Sale Of Investment | 255,678 | 604,594 | 446,961 | 265,825 | 129,790 |
| Investing Cash Flow | $165,497 | $-262,134 | $-291,383 | $989 | $-64,279 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 523,586 | 523,586 | N/A | N/A |
| Debt Repayment | -207 | -188,925 | -188,820 | -48,066 | -47,799 |
| Common Stock Issued | 3,547 | N/A | N/A | 7,758 | 4,075 |
| Other Financing Activity | -10,517 | 181,505 | 151,515 | 137,570 | 137,570 |
| Financing Cash Flow | $-7,177 | $516,166 | $486,281 | $97,262 | $93,846 |
| Beginning Cash Position | 67,182 | 112,666 | 112,666 | 112,666 | 112,666 |
| End Cash Position | 103,216 | 67,182 | 106,238 | 93,631 | 115,422 |
| Net Cash Flow | $36,034 | $-45,484 | $-6,428 | $-19,035 | $2,756 |
| Free Cash Flow | |||||
| Operating Cash Flow | -122,286 | -299,516 | -201,326 | -117,286 | -26,811 |
| Capital Expenditure | -402 | -11,335 | -8,130 | -1,799 | -942 |
| Free Cash Flow | -122,688 | -310,851 | -209,456 | -119,085 | -27,753 |